AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 6408274 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin (1000 units per liter)
Number of subjects: 34
Study 6408274 — intervention group
Group type: COMPARATOR
Intervention: Control (no heparin)
Number of subjects: 34
Study 30547696 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized Cognitive Training (CCT)
Number of subjects: 53
Study 30547696 — intervention group
Group type: COMPARATOR
Intervention: Nonactive control condition
Number of subjects: 53
Study 31783862 — intervention group
Group type: EXPERIMENTAL
Intervention: Luteal phase supplementation with triptorelin (either as a single bolus or multiple injections)
Number of subjects: 1344
Study 31783862 — intervention group
Group type: COMPARATOR
Intervention: Luteal phase with only progesterone (control group)
Number of subjects: 1344
Study 29972000 — intervention group
Group type: EXPERIMENTAL
Intervention: Yin-meridian group (acupuncture at Xuehai (SP 10), Yinlingquan (SP 9), Sanyinjiao (SP 6), Taixi (KI 3), Taichong (LR 3) along yin meridians)
Number of subjects: 90
Study 29972000 — intervention group
Group type: EXPERIMENTAL
Intervention: Yang-meridian group (acupuncture at Futu (ST 32), Zusanli (ST 36), Yanglingquan (GB 34), Guangming (GB 37), Xuanzhong (GB 39) along yang meridians)
Number of subjects: 90
Study 29972000 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation group (routine rehabilitation treatment)
Number of subjects: 90
Study 26932144 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (33,000 international units intravenously for 3 consecutive days)
Number of subjects: 100
Study 26932144 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline administered intravenously)
Number of subjects: 100
Study 24479668 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspheric IOL (Tecnis, Z9000, AMO)
Number of subjects: 30
Study 24479668 — intervention group
Group type: COMPARATOR
Intervention: Spherical IOL (CeeOn Edge, 911A, AMO)
Number of subjects: 30
Study 22405027 — intervention group
Group type: COMPARATOR
Intervention: Single intervention group (contact at baseline only)
Number of subjects: 4678
Study 22405027 — intervention group
Group type: COMPARATOR
Intervention: Dual intervention group (contact at baseline and 3 months)
Number of subjects: 4678
Study 22405027 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall intervention (computer-tailored feedback and information sheet)
Number of subjects: 4678
Study 20846441 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly 30-minute massage sessions
Number of subjects: 45
Study 20846441 — intervention group
Group type: EXPERIMENTAL
Intervention: Massages plus stretching exercises performed twice a day
Number of subjects: 45
Study 20846441 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 45
Study 17715422 — intervention group
Group type: EXPERIMENTAL
Intervention: Selegiline transdermal system (6 mg/24 h)
Number of subjects: 0
Study 17715422 — intervention group
Group type: COMPARATOR
Intervention: Oral selegiline (10 mg)
Number of subjects: 0
Study 16354864 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive mechanical ventilation (NIMV) through a face mask in pressure-support mode plus positive end-expiratory pressure
Number of subjects: 64
Study 16354864 — intervention group
Group type: COMPARATOR
Intervention: Conventional mechanical ventilation (CMV) through a tracheal tube
Number of subjects: 64
Study 16354864 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive mechanical ventilation (NIMV)
Number of subjects: 64
Study 16354864 — intervention group
Group type: COMPARATOR
Intervention: Conventional mechanical ventilation (CMV)
Number of subjects: 64
Study 12077684 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostacyclin (PGl 2)
Number of subjects: 40
Study 12077684 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 12077684 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin
Number of subjects: 40
Study 12077684 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of PGl 2 and aprotinin
Number of subjects: 40
Study 12077684 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with PPS or SIRS
Number of subjects: 40
Study 9654756 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit Association Test (IAT) measuring differential association of concepts with attributes.
Number of subjects: 0
Study 9654756 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit Association Test (IAT)
Number of subjects: 0
Study 8749880 — intervention group
Group type: EXPERIMENTAL
Intervention: Disopyramide (2 mg/kg)
Number of subjects: 12
Study 2522723 — intervention group
Group type: EXPERIMENTAL
Intervention: Celiprolol (200, 400, 600 mg/day)
Number of subjects: 91
Study 2522723 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study 30900658 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal diclofenac patch
Number of subjects: 20
Study 30900658 — intervention group
Group type: COMPARATOR
Intervention: Oral diclofenac sodium (100 mg twice daily)
Number of subjects: 20
Study 27993667 — intervention group
Group type: EXPERIMENTAL
Intervention: Convective radiofrequency thermal therapy with the Rezūm® System
Number of subjects: 197
Study 27993667 — intervention group
Group type: COMPARATOR
Intervention: Control group (rigid cystoscopy with simulated active treatment)
Number of subjects: 197
Study 24801275 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise alone
Number of subjects: 36
Study 24801275 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise with paced auditory serial addition task
Number of subjects: 36
Study 24801275 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise with Tetris
Number of subjects: 36
Study 22807253 — intervention group
Group type: EXPERIMENTAL
Intervention: MTX + prednisone (10 mg of prednisone)
Number of subjects: 0
Study 22807253 — intervention group
Group type: COMPARATOR
Intervention: MTX + placebo
Number of subjects: 0
Study 16490095 — intervention group
Group type: EXPERIMENTAL
Intervention: Entonox (50% nitrous oxide and oxygen)
Number of subjects: 14
Study 16490095 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous morphine
Number of subjects: 14
Study 16490095 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 14
Study 12932067 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia with hyperbaric bupivacaine 0.5% 5 mg and fentanyl 25 microg
Number of subjects: 40
Study 12932067 — intervention group
Group type: COMPARATOR
Intervention: Total intravenous anaesthesia with propofol and remifentanil
Number of subjects: 40
Study 12932067 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia
Number of subjects: 40
Study 12932067 — intervention group
Group type: COMPARATOR
Intervention: Total intravenous anaesthesia
Number of subjects: 40
Study 10720278 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 microg/kg rhNGF
Number of subjects: 270
Study 10720278 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 microg/kg rhNGF
Number of subjects: 270
Study 10720278 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270
Study 10720278 — intervention group
Group type: EXPERIMENTAL
Intervention: Both doses of NGF
Number of subjects: 270
Study 8639017 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling by hospital patient representatives
Number of subjects: 190
Study 8639017 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 190
Study 1641137 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemoline
Number of subjects: 46
Study 1641137 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 6435046 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 75
Study 6435046 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin V
Number of subjects: 75
Study 6435046 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 30474909 — intervention group
Group type: EXPERIMENTAL
Intervention: Active SMS with hypertension specific management
Number of subjects: 0
Study 30474909 — intervention group
Group type: COMPARATOR
Intervention: Passive SMS (health behaviors SMS alone)
Number of subjects: 0
Study 30474909 — intervention group
Group type: EXPERIMENTAL
Intervention: Active SMS
Number of subjects: 0
Study 30474909 — intervention group
Group type: COMPARATOR
Intervention: Passive SMS
Number of subjects: 0
Study 29038317 — intervention group
Group type: EXPERIMENTAL
Intervention: £0.10 levy on sugar-sweetened beverages (SSBs)
Number of subjects: 37
Study 25575599 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized mail-based contact strategy
Number of subjects: 308
Study 25575599 — intervention group
Group type: COMPARATOR
Intervention: Generic mail-based contact strategy
Number of subjects: 308
Study 25575599 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized telephone-based contact strategy
Number of subjects: 308
Study 25575599 — intervention group
Group type: COMPARATOR
Intervention: Generic telephone-based contact strategy
Number of subjects: 308
Study 25575599 — intervention group
Group type: EXPERIMENTAL
Intervention: Age ≤40 years
Number of subjects: 308
Study 25575599 — intervention group
Group type: EXPERIMENTAL
Intervention: Minority race
Number of subjects: 308
Study 23769413 — intervention group
Group type: EXPERIMENTAL
Intervention: Active TMS
Number of subjects: 142
Study 23769413 — intervention group
Group type: COMPARATOR
Intervention: Sham TMS
Number of subjects: 142
Study 20831758 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine bone mineral (BioOss(®)) seeded with mononuclear stem cells harvested from the posterior iliac crest
Number of subjects: 12
Study 20831758 — intervention group
Group type: COMPARATOR
Intervention: Bovine bone mineral (BioOss(®)) mixed with autogenous bone (harvested from the retromolar area)
Number of subjects: 12
Study 19111485 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryostripping
Number of subjects: 120
Study 19111485 — intervention group
Group type: COMPARATOR
Intervention: Endovenous laser ablation
Number of subjects: 120
Study 17904982 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial metabolic score of 0
Number of subjects: 556
Study 17904982 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial metabolic score of 1
Number of subjects: 556
Study 17904982 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial metabolic score of 2 or more
Number of subjects: 556
Study 15066528 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS) at 5 Hz, 100 pulses, 80% threshold for corticobulbar activation
Number of subjects: 12
Study 15066528 — intervention group
Group type: COMPARATOR
Intervention: Repetitive transcranial magnetic stimulation (rTMS) at 1 Hz
Number of subjects: 12
Study 15066528 — intervention group
Group type: COMPARATOR
Intervention: Repetitive transcranial magnetic stimulation (rTMS) at 10 Hz
Number of subjects: 12
Study 15066528 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 12
Study 11136913 — intervention group
Group type: EXPERIMENTAL
Intervention: Low bone mineral density (BMD) in female stroke patients
Number of subjects: 63
Study 11136913 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowest quartile of BMD in women
Number of subjects: 63
Study 11136913 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in BMD
Number of subjects: 63
Study 11136913 — intervention group
Group type: EXPERIMENTAL
Intervention: Low BMD in women
Number of subjects: 63
Study 9628239 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP‐1 (7‐36 amide)
Number of subjects: 10
Study 9628239 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl with 1% human serum albumin)
Number of subjects: 10
Study 7886781 — intervention group
Group type: EXPERIMENTAL
Intervention: IVR 400 micrograms/kg plus DEC 6 mg/kg
Number of subjects: 57
Study 7886781 — intervention group
Group type: COMPARATOR
Intervention: IVR 400 micrograms/kg
Number of subjects: 57
Study 7886781 — intervention group
Group type: COMPARATOR
Intervention: DEC 6 mg/kg
Number of subjects: 57
Study 3126636 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg nitroglycerin (NTG) patch
Number of subjects: 24
Study 3126636 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 24
Study 31628507 — intervention group
Group type: EXPERIMENTAL
Intervention: OSU6162
Number of subjects: 56
Study 31628507 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 30829679 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 g of lactoferrin and 0.2 g of lysozyme daily for 16 weeks
Number of subjects: 214
Study 30829679 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 214
Study 28697797 — intervention group
Group type: EXPERIMENTAL
Intervention: SELF-FIT intervention (experimental group)
Number of subjects: 26
Study 28697797 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 26
Study 25332420 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin plus irinotecan
Number of subjects: 370
Study 25332420 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin plus etoposide
Number of subjects: 370
Study 24294684 — intervention group
Group type: EXPERIMENTAL
Intervention: Specially processed cereal (SPC) treatment
Number of subjects: 39
Study 24294684 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 39
Study 21683053 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio feedback with cognitive preparation
Number of subjects: 40
Study 21683053 — intervention group
Group type: COMPARATOR
Intervention: Audio feedback only
Number of subjects: 40
Study 18270751 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 13
Study 18270751 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 16487947 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyslexic adults
Number of subjects: 12
Study 16487947 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 12
Study 15552536 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (600 mg/day) added to fluphenazine (5-10 mg/day)
Number of subjects: 11
Study 15552536 — intervention group
Group type: COMPARATOR
Intervention: Sole fluphenazine (5-10 mg/day)
Number of subjects: 11
Study 11051235 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD-BIO (Cisplatin, Vinblastine, Dacarbazine followed by IL-2 and IFN-alpha2b)
Number of subjects: 82
Study 11051235 — intervention group
Group type: COMPARATOR
Intervention: CVD (Cisplatin, Vinblastine, Dacarbazine)
Number of subjects: 82
Study 11051235 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD-BIO
Number of subjects: 82
Study 9089819 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipsychotic medications
Number of subjects: 22
Study 9089819 — intervention group
Group type: COMPARATOR
Intervention: No antipsychotic medications
Number of subjects: 22
Study 1447391 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole 25% dental gel administered 1 x a week for 2 weeks
Number of subjects: 61
Study 1447391 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole 15% dental gel applied 1 x a week for 2 weeks
Number of subjects: 61
Study 1447391 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole 15% dental gel applied 2 x a week for 2 weeks
Number of subjects: 61
Study 1447391 — intervention group
Group type: COMPARATOR
Intervention: Subgingival scaling performed 1 x only
Number of subjects: 61
Study 2863676 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 69
Study 2863676 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study 31345167 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality Improvement Capacity Assessment (QICA)
Number of subjects: 0
Study 27817095 — intervention group
Group type: COMPARATOR
Intervention: Polygenic score
Number of subjects: 678
Study 27817095 — intervention group
Group type: EXPERIMENTAL
Intervention: Elementary school-based universal preventive intervention
Number of subjects: 678
Study 27104681 — intervention group
Group type: EXPERIMENTAL
Intervention: Score for Neonatal Acute Physiology‐II
Number of subjects: 171
Study 25741518 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot pack
Number of subjects: 126
Study 25741518 — intervention group
Group type: EXPERIMENTAL
Intervention: Lukewarm-water-soaked gauze
Number of subjects: 126
Study 25741518 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 126
Study 22122217 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 77
Study 22122217 — intervention group
Group type: COMPARATOR
Intervention: General Stress Management (GSM)
Number of subjects: 77
Study 22122217 — intervention group
Group type: COMPARATOR
Intervention: No Treatment (NT)
Number of subjects: 77
Study 20858878 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management counseling plus heart failure education
Number of subjects: 902
Study 20858878 — intervention group
Group type: COMPARATOR
Intervention: Heart failure education alone
Number of subjects: 902
Study 17910618 — intervention group
Group type: EXPERIMENTAL
Intervention: Indinavir combined with low-dose ritonavir
Number of subjects: 656
Study 17910618 — intervention group
Group type: EXPERIMENTAL
Intervention: Saquinavir combined with low-dose ritonavir
Number of subjects: 656
Study 17910618 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir combined with low-dose ritonavir
Number of subjects: 656
Study 17910618 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 656
Study 15616073 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefopam 20 mg
Number of subjects: 77
Study 15616073 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 10 mg
Number of subjects: 77
Study 15616073 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline (control group)
Number of subjects: 77
Study 12391054 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (30 mg iv bolus)
Number of subjects: 18
Study 10489000 — intervention group
Group type: COMPARATOR
Intervention: Control group (age- and sex-matched)
Number of subjects: 14
Study 10489000 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjects with low back pain
Number of subjects: 14
Study 10489000 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 14
Study 8946182 — intervention group
Group type: EXPERIMENTAL
Intervention: Aircast Air‐Stirrup ankle brace
Number of subjects: 66
Study 8946182 — intervention group
Group type: EXPERIMENTAL
Intervention: DonJoy R.O.M.‐Walker brace
Number of subjects: 66
Study 8946182 — intervention group
Group type: COMPARATOR
Intervention: Both braces
Number of subjects: 66
Study 1789399 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide powder 400 micrograms daily
Number of subjects: 116
Study 1789399 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide powder 800 micrograms daily
Number of subjects: 116
Study 1789399 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide aerosol 400 micrograms daily
Number of subjects: 116
Study 1789399 — intervention group
Group type: COMPARATOR
Intervention: Placebo powder
Number of subjects: 116
Study 6786791 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrapped
Number of subjects: 6
Study 6786791 — intervention group
Group type: EXPERIMENTAL
Intervention: Taped
Number of subjects: 6
Study 6786791 — intervention group
Group type: COMPARATOR
Intervention: No external support
Number of subjects: 6
Study 6786791 — intervention group
Group type: COMPARATOR
Intervention: Normal (control)
Number of subjects: 6
Study 6786791 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle inverting (experimental)
Number of subjects: 6
Study 31751254 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalization mechanisms in mobile applications (Feedback, Goal Setting, User Targeting, Inter-human Interaction)
Number of subjects: 17
Study 31751254 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamification-related elements in mobile applications
Number of subjects: 17
Study 31751254 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior change theories in mobile applications
Number of subjects: 17
Study 29665854 — intervention group
Group type: EXPERIMENTAL
Intervention: REACT intervention delivered over 12 months by trained facilitators
Number of subjects: 768
Study 29665854 — intervention group
Group type: COMPARATOR
Intervention: Minimal control intervention
Number of subjects: 768
Study 29665854 — intervention group
Group type: EXPERIMENTAL
Intervention: REACT intervention
Number of subjects: 768
Study 28912191 — intervention group
Group type: EXPERIMENTAL
Intervention: High energy administration (30 kcal/kg/day) starting within 24 hours of hospital admission
Number of subjects: 0
Study 28912191 — intervention group
Group type: COMPARATOR
Intervention: Low energy administration during the first 72 hours of hospital admission
Number of subjects: 0
Study 26624850 — intervention group
Group type: EXPERIMENTAL
Intervention: TDF-FTC
Number of subjects: 400
Study 26624850 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study 22549800 — intervention group
Group type: EXPERIMENTAL
Intervention: Tele-based nurse-delivered five-session psycho-educational intervention (N = 372)
Number of subjects: 740
Study 22549800 — intervention group
Group type: COMPARATOR
Intervention: Usual care (N = 368)
Number of subjects: 740
Study 21541815 — intervention group
Group type: EXPERIMENTAL
Intervention: Biliopancreatic diversion (BPD) in mildly obese patients (BMI 30-35)
Number of subjects: 30
Study 21541815 — intervention group
Group type: EXPERIMENTAL
Intervention: Biliopancreatic diversion (BPD) in simply overweight patients (BMI 25-30)
Number of subjects: 30
Study 21541815 — intervention group
Group type: COMPARATOR
Intervention: Control group (38 diabetic patients on medical therapy)
Number of subjects: 30
Study 18807128 — intervention group
Group type: EXPERIMENTAL
Intervention: omeprazole 10 mg
Number of subjects: 355
Study 18807128 — intervention group
Group type: EXPERIMENTAL
Intervention: omeprazole 20 mg
Number of subjects: 355
Study 18807128 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 355
Study 18807128 — intervention group
Group type: EXPERIMENTAL
Intervention: omeprazole 10 mg and 20 mg
Number of subjects: 355
Study 16556248 — intervention group
Group type: EXPERIMENTAL
Intervention: Migraineurs in the premenstrual phase
Number of subjects: 32
Study 16556248 — intervention group
Group type: COMPARATOR
Intervention: Migraineurs and controls during ovulation and premenstrual phases
Number of subjects: 32